Cargando…

Sleep duration and multimorbidity in Luxembourg: results from the European Health Examination Survey in Luxembourg, 2013–2015

OBJECTIVES: We estimated the prevalence of short sleep duration and multimorbidity in Luxembourg, and assessed whether sleep duration was associated with multimorbidity after adjusting for sociodemographic and behavioural characteristics. DESIGN: Cross-sectional study. PARTICIPANTS: Data from 1508 L...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz-Castell, Maria, Makovski, Tatjana T, Bocquet, Valéry, Stranges, Saverio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707670/
https://www.ncbi.nlm.nih.gov/pubmed/31439597
http://dx.doi.org/10.1136/bmjopen-2018-026942
Descripción
Sumario:OBJECTIVES: We estimated the prevalence of short sleep duration and multimorbidity in Luxembourg, and assessed whether sleep duration was associated with multimorbidity after adjusting for sociodemographic and behavioural characteristics. DESIGN: Cross-sectional study. PARTICIPANTS: Data from 1508 Luxembourg residents (48% men and 52% women) aged 25 to 64 years came from the European Health Examination Survey 2013–2015. OUTCOME MEASURES: Short sleep duration and multimorbidity. RESULTS: Participants reported sleeping 6.95 hours/night during work days, nearly 1 hour less than during non-work days (7.86 hours/night). Nearly half of participants reported having been diagnosed with ≥2 chronic conditions/diseases. Short sleep duration was associated with the number of chronic conditions (OR 4.65, 95% CI 1.48 to 14.51; OR 7.30, 95% CI 2.35 to 22.58; OR 6.79, 95% CI 2.15 to 21.41 for 1, 2 and ≥3 chronic conditions/diseases, respectively), independently of socioeconomic and behavioural characteristics. CONCLUSIONS: Health promotion programmes should aim at improving and promoting healthy lifestyles among the general population to improve sleep habits as well as decrease multimorbidity in middle-aged adults.